Clinical Trial Update: ROS Signaling in Endothelial Function [NA]

View source ↗

Summary

A Boston University–sponsored clinical trial investigating reactive oxygen species signaling and endothelial function in cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Boston University | Conditions: Cardiovascular Disease | NA | Status: COMPLETED